Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASE: Tapering DMARDs vs usual care in elderly rheumatoid arthritis
2026-525221-21-01Phase 4Authorised
- Sponsor
- Aalborg University Hospital
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methotrexate, adalimumab, etanercept, infliximab, certolizumab pegol and 12 more in rheumatoid arthritis (RA) (2 arms), sponsored by Aalborg University Hospital. Planned start Jul 2026; status: authorised.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2026-525221-21-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525221-21-01.